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The evaluation of renovascular disease (RVD)
has traditionally been hampered by the lack of reli-
able noninvasive diagnostic modalities. Contrast
arteriography via arterial catheterization remains the
gold standard for both diagnostic accuracy and
treatment planning. Noninvasive studies such as
Duplex scanning and captopril renal scintography
are used principally as screening modalities to mini-
mize unnecessary angiography but cannot provide
the anatomic information required for treatment
planning. Although contrast arteriography is gener-
ally safe for most patients across the wide spectrum
of potential clinical presentations seen with athero-
sclerotic RVD, those patients with significant
azotemia and/or acute pulmonary edema are at
considerable risk for major complications of contrast
arteriography. In a previous report from our institu-
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tion that surveyed complications of angiography in
1000 patients, we noted an 11% rate of clinically sig-
nificant contrast-induced renal failure in patients
with any degree of antecedent renal dysfunction.1 In
the setting of antecedent renal dysfunction, iodinat-
ed contrast–induced acute renal failure can be
severe, often delaying definitive treatment of RVD,
which complicates the management of pulmonary
edema, and may precipitate the need for dialysis.
Some have advocated the use of CO2 angiography
to eliminate contrast nephrotoxicity, but our experi-
ence with this technique is that it provides inade-
quate resolution for accurate diagnosis of RVD. In
addition, gadolinium can be substituted for iodine-
containing contrast agents, but the cost of this agent
is excessive. Furthermore, because juxtarenal ather-
osclerosis is commonly encountered in patients with
RVD, catheter-based angiography (irrespective of
the nature of the contrast agent) may be complicat-
ed by potentially devastating atheroembolism to
renal, mesenteric, and lower extremity arteries.
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For these reasons, a noninvasive imaging
modality that provides sufficient anatomic detail of
aortic, visceral, and renovascular anatomy to per-
mit specific treatment selection among the various
options for management of RVD would be opti-
mal. This is particularly true in patients with sig-
nificant azotemia and/or pulmonary edema.
Experience in our unit and elsewhere with mag-
netic resonance angiography (MRA) has suggested
that this imaging modality can provide accurate
“angiographic” assessment of aortic and renovas-
cular anatomy.2-12 Prompted by the wish to avoid
the potential complications of contrast angiogra-
phy in patients with fulminant presentations of
RVD and after a favorable experience with correl-
ative information in patients whose condition was
studied with both MRA and contrast angiogra-
phy,2 we instituted a selective policy of surgical
management of RVD with MRA as the sole imag-
ing modality. In this article, results achieved over a
five-year interval with this policy are reviewed.
Table I. Clinical presentation, surgical treatment and results of treatment in 25 patients
Complete
Patient Condition (Cr, mg/dL) Operation RAR* (Y/N) Outcome HBP†
1 Severe HBP (3.0) HRBPG Y Cr 2.0 @ 4 yrs I
2 Severe HBP, › Cr (3.5) AAA + bilateral AoR Y Cr 2.0 @ 3.5 yrs I
3 HBP encephalopathy › Cr (4.2) Bilateral endart Y Cr 2.5fi –5.0 @ 3 yrs I
4 Pulmonary edema, AAA (2.1) AAA + AoR Y Cr 1.5 @ 2.5 yrs I
5 Pulmonary edema, AAA › Cr (4.0) AAA/rt endart/lt AoR Y Cr 4.0 (refused dialysis) NA
6 Severe HBP › Cr (2.1) AFBP/bilateral endart Y Cr 1.5 @ 2 yrs I
7 Cholesterol embolism › Cr (3.5) Lt AoR Y Dialysis @ 1 yr NA
8 Pulmonary edema/dialysis › Cr (4.2) Bilateral endart Y Cr 1.5 @ 2 yrs I
9 HBP encephalopathy (4.0) Bilateral AoR Y Cr 3.0 @ 2 yrfi dialysis @ 3 yr I
10 Pulmonary edema › Cr (3.0) AAA/bilateral endart Y Cr 2.2 @ 2 yr I
11 Pulmonary edema (2.4) Suprarenal AAA/rt endart, Y Cr 1.4 @ 1 yr I
lt nephrectomy
12 Pulmonary edema (2.0) Visceral endart‡ Y Cr 1.4 @ 1 yr I
13 Pulmonary edema › Cr (2.9) AAA/rt AoR, lt nephrectomy Y Cr 1.2 @ 6 mo I
14 Severe HBP › Cr (2.0) Type IV TAA/lt AoR N Cr 2.0 @ 6 mo I
15 › Cr/lt renal CA (2.4) HRBPG; lt nephrectomy (partial) N Cr 2.0 @ 6 mo NA
16 HBP encephalopathy (1.4) HRBPG N Cr same @ 5-6 mo C
17 › Cr/type IV TAA (3.0) TAA repair/rt endart/lt AoR Y Cr 1.8 @ 6 mo NA
18 Pulmonary edema/type IV TAA (3.0) TAA repair/bilateral AoR Y Cr 2.0fi died @ 3 mo I
19 Severe HBP/AAA (1.6) Suprarenal AAA/lt AoR N AoR graft failure U
20 Severe HBP › Cr (1.6) Visceral endart/AAA Y Cr 1.2 @ 6 mo I
21 Severe HBP (1.8) Bilateral endart Y Cr 1.5 @ 1 yr I
22 Pulmonary edema/dialysis › Cr (5.0) Bilateral endart Y Cr 2.5 @ 1 yr I
23 › Cr (2.8) Visceral endart Y Cr 2.8 @ 1 yr U
24 Pulmonary edema › Cr (3.0) Lt endart Y Cr 1.5 @ 1 yr I
25 Renal failure after CABG (6.0) Bilateral endart Y Cr 1.8 @ 1 yr NA
HBP, Hypertension; HRBPG, hepatorenal bypass graft; Y, yes; Cr, creatinine level; I, improved; › Cr, recognized › in serum creatinine
in year prior to treatment; AoR, aortorenal bypass graft; endart, transaortic endarterectomy; rt, right; lt, left; NA, not applicable (ie,
HBP not a major component of the clinical presentation); AFBP, aortobifemoral bypass grafting; N, no; CA, renal carcinoma; C, cured;
U, unchanged; CABG, coronary artery bypass grafting.
*Bilateral revascularization or reconstruction to a single functioning kidney.
†Response of hypertension to revascularization.
‡Transaortic celiac/superior mesenteric and bilateral renal endarterectomy.
required temporary dialysis before operation. Such
renal dysfunction combined with the desire to avoid
nephrotoxic contrast agents in proximity to an oper-
ation wherein renal blood flow would be temporari-
ly interrupted were the principal reasons for avoid-
ing contrast arteriography. Details of patients’ clini-
cal condition, surgical treatment, and outcome are
given in Table I and II.
Aortic and renal artery MRA was carried out
with a gadolinium-enhanced and three-dimensional
(3-D) phase contrast technique. All magnetic reso-
nance examinations were performed on 1.5-T Signa
scanners (General Electric Medical Systems, Mil-
waukee, Wis), with software versions 4.8-5.2. The
body coil was used for all studies. The renal MRA
protocol consisted of three sequences. First, a T1-
weighted sagittal scan was obtained to localize the
renal artery origins and to evaluate the abdominal
aorta. The scan was centered on the xyphoid
process; the following parameters were used: 24
interleaved slices, 10-mm slice thickness, 426/12
(time to repeat/time to echo), 40-cm field of view,
256 · 128 matrix, two excitations, respiratory com-
pensation, and no phase wrap. Scan time was
approximately 4 minutes.
The next sequence was a gadolinium-enhanced 3-
D spoiled gradient recalled MRA. This sequence has
been modified over time as hardware and software
upgrades have become available. The details of these
earlier versions of the gadolinium-enhanced 3-D
spoiled gradient recalled sequence have been described
previously.3,4 The current parameters are coronal 3-D
slab centered on the aortic bifurcation, fast spoiled gra-
dient recalled pulse sequence, 28 partitions, 2.5-mm
thickness, 32-cm three quarter field of view, 12/2.9
(TR/TE), flip angle of 40 degrees, 256 · 128 matrix,
and one excitation. This results in a typical scan time
of 34 seconds, during which patients either suspend
respiration or breath with slow, shallow inspiration.
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PATIENTS AND METHODS
Over a five-year interval (May 1993-May 1998),
25 patients underwent surgical renal artery recon-
struction (RAR) with MRA as the sole renovascular
imaging modality. These patients represented 15% of
all RARs performed on the senior author’s (R.P.C.)
service over this time period. Clinical presentations
suggested atherosclerotic RVD in all patients (many
patients had multicomponent conditions) and
included poorly controlled hypertension (diastolic
blood pressure, ‡ 90 mm Hg; receiving ‡ 3 antihy-
pertensive medications), hospitalization for hyper-
tensive crises and/or acute pulmonary edema, and
documented deterioration of renal function within
one year of operation. Of 10 patients with acute
pulmonary edema, none was found to have a car-
diogenic cause, and 9 of 10 patients underwent ech-
ocardiography for the verification of adequate or
normal left ventricular systolic function. Three
patients with pulmonary edema were initially inves-
tigated with cardiac catheterization and found to
have noncritical coronary artery disease (although
one right coronary stent was deployed). One patient
had moderate aortic stenosis that was felt insufficient
to explain pulmonary edema. Five patients had
hypertensive encephalopathy and/or lacunar strokes
as a component of hypertensive crises. Thirteen
patients had associated aortic pathologic conditions
(12 aneurysms, 1 aortoiliac occlusive disease), and
eight of these patients also underwent noncontrast
computed tomography scans. Three patients were
initially referred for treatment of aneurysm disease,
but two of these patients had been hospitalized with
azotemia and pulmonary edema. All remaining
patients were referred with at least clinical suspicion
of RVD. Significant azotemia (creatinine level, ‡ 2.0
mg/dL) was present in all but four patients, with 14
of 25 patients having extreme renal dysfunction
(creatinine level, ‡ 3.0 mg/dL). Two patients
Table II. Details of surgical treatment
Procedure n
Hepatorenal BPG 3
Transaortic endarterectomy 8 (7 bilateral, 1 unilateral)
Aortorenal BPG 1
Combined aortic and renovascular repair (n = 13)
Infrarenal AAA + bilateral aortorenal BPG 2
Infrarenal AAA + unilateral aortorenal BPG 2
Suprarenal AAA + left aortorenal BPG [one patient with right renal endarterectomy] 3
Infrarenal aortic graft (2 AAA, 1 AIOD) + bilateral transaortic endarterectomy (2 with mesenteric endarterectomy) 3
Type IV TAA + right renal endarterectomy (1) or left aortorenal BPG (2) 3
BPG, Bypass graft; AIOD, aortoiliac occlusive disease.
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The volume of gadolinium chelate has remained
the same throughout the study period, although the
rate of injection has increased. For each patient, 0.2
to 0.3 mmol/kg of contrast in the form of gadodi-
amide (Omniscan; Nycomed, New York, NY) or
gadopentetate dimeglumine (Magnevist; Berlex
Laboratories, Wayne, NJ) was injected through a
peripheral intravenous line. A dosage of 0.3
mmol/kg was used in most patients and in all
patients since 1996. The volume of contrast was not
modified for patients with renal insufficiency.
Contrast was injected by hand during the 5-minute
and 3.5-minute scans, commencing with the onset
of the scan and ending 20 to 30 seconds before
completion of the acquisition. For the 28-second
scans, contrast was administered either by hand or
with a magnetic resonance–compatible power injec-
tor (Medrad, Pittsburgh, Pa). Injection of contrast
was begun 10 seconds before initiation of the acqui-
sition and timed to end with 15 to 20 seconds of
scan time remaining. When the power injector was
used, the injection rate was 2 mL/sec.
The major change among the different versions
of the scan has been progression from a 5-minute
scan3 applied in four patients, to a 3.5-minute scan2
used in nine patients to the current 34 seconds used
in 12 patients. A second scan has always been
obtained to visualize the venous phase of the
gadolinium.4 The brevity of the current sequence
allows rapid repetition of the scan several times,
which can provide additional important information
during the arterial phase of the gadolinium. For
example, in patients with slow circulation times the
best arterial enhancement may occur on the second
scan. Furthermore, the dynamic nature of the 28-sec-
ond scan may reveal a nephrogram that is delayed as
the result of severe renal artery stenosis or occlusion.
An axial 3-D phase-contrast MRA was obtained
that was centered at the level of the renal arteries in
all patients unless the study was terminated early
because of patient or equipment issues. The scan
parameters remained stable over the period of
review: 32-cm to 36-cm field of view, 25/9 (average
TR/TE), 28 partitions, 1.5-mm thick, velocity
encoding 40 cm/sec, 20-degree flip angle, 256 ·
128 matrix, one excitation, no phase wrap, and flow
encoding in 3 directions. The average time for this
acquisition is 5.5 minutes.
The MRAs were interpreted at various genera-
tions of workstations (all commercially available at
the time from General Electric) from the source
images and multiplanar and curved reformats creat-
ed by a radiologist. Shaded surface or volume 3-D
reconstructions were not used. Determination of
hemodynamically significant renal artery stenosis
was made from a combination of information avail-
Fig 1. Representative renal MRA in patient 16
(Table I,) with hypertensive encephalopathy. A,
High-grade proximal right renal artery stenosis
(arrow) associated with aortic plaque. Note the
signal drop-out at the lesion and poststenotic
dilatation beyond the lesion. B, Gadolinium
nephrogram shows decreased right renal size
(arrows) and cortical thickness compared with left
kidney consistent with hemodynamic significance
of right renal artery stenosis. C, Lateral MRA aor-
togram shows a widely patent celiac axis origin
(arrow) before hepatorenal bypass graft.A
B
C
able from the three magnetic resonance sequences.
The anatomic images (degree of stenosis, presence
of poststenotic dilatation) from the gadolinium-
enhanced sequence provide anatomic images similar
to conventional arteriography because (unlike the
phase-contrast sequence) they are not subject to
flow-related image degradation. Size and intensity of
the gadolinium-enhanced nephrogram and com-
plete dephasing in the proximal renal artery were
considered indirect but helpful findings consistent
with flow-reducing renal artery stenosis. All MRA
studies were jointly interpreted by the treating sur-
geon (R.P.C.) and a senior vascular radiologist
(J.L.K.). Previous work in our unit verified the accu-
racy of renal MRA with conventional arteriography
as a “gold standard.”2
The definition of terms used to characterize clin-
ical presentations and results of treatment are as fol-
lows: The terms severe and poorly controlled hyper-
tension are used interchangeably. Hypertensive
enchephalopathy was deemed mental status changes
and/or lacunar stroke in patients with high blood
pressure (HBP) so severe as to require hospitaliza-
tion. All patients with pulmonary edema were hos-
pitalized under urgent circumstances. Hypertension
response to revascularization was classified as
“improved” if there was a reduction of one or more
medications and postoperative diastolic blood pres-
sure was 90 mm Hg or less; lesser responses were
classified as “unchanged.” Patients cured of hyper-
tension were normotensive when not taking medica-
tions. Five patients did not have significant hyper-
tension as part of the clinical presentation, and no
disposition with respect to postoperative hyperten-
sion was recorded. Renal function response to revas-
cularization was considered favorable if a reduction
of 20% or more in serum creatinine level was record-
ed. Follow-up intervals ranged from 5 months to 4
years and are recorded for individual patients in
Table I, where intervals are rounded to the nearest
6-month interval.
RESULTS
Aortic and Renal MRA. Only four patients
were found to have unilateral RVD (Fig 1), and one
of these patients harbored a renal cell carcinoma in
the contralateral kidney (patient 15). The remaining
patients had either bilateral severe stenoses or high-
grade stenosis to a single functioning kidney (6
patients). Two of the latter patients had had prior
nephrectomies, and the remaining four patients had
both total artery occlusion and renal length 6 cm or
less; two of these patients underwent contralateral
nephrectomy. Verification of the hemodynamic sig-
nificance of the RVD was made at operation. In four
patients, intraoperative pressure measurements were
recorded from the aorta and the renal artery beyond
the lesion. This practice was abandoned in favor of
simple intraoperative pulse palpation to avoid blood
staining in the renal artery wall before its recon-
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Fig 2. Scattergram of renal function response to renal revascularization at 1 month after operation.
Dotted lines represent patients 5, 7, 19, and 23 (Table I) without favorable response to revascularization.
struction. Hemodynamic significance was verified by
the absence of a palpable pulse in the renal artery
beyond the lesion. Pressure-reducing RVD in the
main renal arteries was verified for 37 of 38 recon-
structed main renal arteries with one false-positive
(high-grade stenosis suspected on MRA; no pressure
reduction [verified by pressure measurement] found
in renal artery at operation [patient 23]) MRA.
There were no false-negative renal MRA results for
patients undergoing unilateral RAR with a patent
contralateral artery.
Surgical treatment and results. Specifics of oper-
ative therapy are detailed in Tables I and II. The
planned surgical treatment based on the MRA was
executed in 23 of 25 patients. The operation of
patient 9 was changed from planned transaortic
endarterectomy to infrarenal aortic replacement and
bilateral aortorenal bypass grafts because of aneurys-
mal degeneration of the renal artery origins felt not
amenable to endarterectomy. Patient 18 underwent
intended right renal endarterectomy in conjunction
with type IV thoracoabdominal aortic aneurysm
(TAA) repair. This was converted to an aortorenal
bypass graft because of an unsatisfactory technical
result. Hepatorenal bypass grafting was performed
with reversed greater saphenous vein whereas aor-
torenal bypass graftings were performed with PTFE
conduits originated from a simultaneously or previ-
ously placed (one case) aortic Dacron prosthesis.
Transaortic endarterectomy was accomplished in all
cases by a longitudinal aortotomy with the crossclamp
above the superior mesenteric artery or in a supraceli-
ac position. Combined aortic and RAR (Table II) was
performed for associated aneurysm disease (11/13
patients) and a single case of aortoiliac occlusive dis-
ease. A single patient required infrarenal aortic resec-
tion for the sole purpose of originating bilateral aor-
torenal grafts, because the anatomy of the visceral aor-
tic segment was not amenable to endarterectomy.
However, the primary indication for surgical inter-
vention was the RVD in all but a single case, and
aneurysms of two patients were less than 5 cm and
would have been observed but for the needed reno-
vascular repair. There was a single failure of a RAR in
a patient (patient 19) undergoing suprarenal abdom-
inal aortic aneurysm (AAA) repair. Aortorenal bypass
grafting was performed on a diseased artery that was
supplying a 7-cm kidney in a patient with unilateral
disease and a baseline creatinine level of 1.6 mg/dL
(patient 19). In retrospect, a nephrectomy would
have been the better treatment. In the remaining 24
patients, clinical follow-up (ie, those with reconstruc-
tion to a single functioning kidney) or a postoperative
imaging study (renal scan, repeat MRA, or computed
tomography scan) verified patency of the RARs.
There was no perioperative death nor postoperative
renal failure that required dialysis. Major morbidity
included a single case each of respiratory failure
requiring tracheostomy (patient 23) and paraplegia
after type IV TAA repair (patient 18). Two late deaths
occurred at 3 months after operation; one death was
related to renal failure (patient 5 refused dialysis), and
one death was the result of pulmonary and infectious
complications in the patient who sustained paraplegia.
Functional results of RAR at follow-up intervals
ranging from 5 months to 4 years are detailed in
Table I and Fig 2. Early improvement (assessed at 1
month after operation) in renal excretory function
was noted in 20 of 24 patients. (One patient had
normal preoperative function.) Of the four patients
whose condition were considered early treatment
failures in terms of renal function or hypertension
control (patients 5, 7, 19, and 23), one was related
to the single false-positive MRA, one to bypass graft
failure, and two cases where renal revascularization
produced no favorable effect on renal function. One
of these patients refused dialysis and died 4 months
after operation; the other patient required the insti-
tution of dialysis at 1 year after the repair of a high-
grade stenosis to a single functioning kidney on a
background of major renal atheroembolism at the
time of aortic reconstruction that had been per-
formed elsewhere. Patients 3 and 9 had late deterio-
ration of renal function at 3 years after operation,
despite early favorable responses in both hyperten-
sion control and renal function; one patient is cur-
rently on dialysis. Both of these patients were hospi-
talized with malignant hypertension and lacunar
strokes. Renal revascularization produced prompt
and dramatic results in terms of reversing the hyper-
tension and at least stabilization of renal function for
3 years. Favorable results with respect to hyperten-
sion control (Table I) were noted in 18 of 20
patients; a single patient has been cured.
DISCUSSION
The results achieved in the present study confirm
that renal MRA can supplant contrast angiography
before surgical RAR, at least in those circumstances
where we have chosen to apply this policy (in azotemic
patients at considerable risk for complications from
angiography). Our patient cohort was remarkable for
the preponderance of fulminant presentations of
RVD-hypertensive crises and/or acute pulmonary
edema. The correlative finding of significant renal dys-
function in 22 of 25 patients made avoidance of con-
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trast angiography intuitively logical because the clinical
presentation appeared to dictate, or at least predict, the
pathologic and functional significance of the RVD,
which was then confirmed by MRA. Despite consider-
able and generally favorable experience with the accu-
racy of renal MRA as compared with conventional
angiography, we believe this to be the first report
detailing surgical RAR with MRA as the sole preoper-
ative imaging modality, although others12 have at least
alluded to this strategy.
Central to the premise of this report is the diag-
nostic accuracy of renal MRA, which has recently
been reviewed in detail.5 Virtually all of the available
literature has emanated from centers with consider-
able experience in the development of MRA in a vari-
ety of anatomic locales. When compared with a con-
trast angiography gold standard, representative con-
temporary reports quote sensitivities that range from
85% to 100% and specificities from 71% to 98%6-11
for the detection of atherosclerotic renal artery
stenosis. In a recent report from our group, we urged
caution and emphasized that, similar to MRA in
other anatomic locations, renal MRA has a tendency
to overestimate the degree of stenosis particularly in
discerning the presence of a hemodynamically signif-
icant stenosis in arteries with 50% to 75% diameter
reduction.2 Experience and technical refinements
with MRA can minimize such errors, and it is impor-
tant to emphasize that the MRA must be interpreted
globally (ie, considering all components of the study
as opposed to merely inspecting the renal artery pro-
jection angiogram; Fig 1). Similar to interpreting
renal artery contrast arteriograms, imaging features
such as poststenotic dilatation of the renal artery and
kidney size and intensity of nephrogram provide indi-
rect evidence of the significance of the renal artery
lesion. Prince et al12 reported that, in patients with
unilateral disease, the magnetic resonance features of
renal length, cortical thickness, and enhancement
were significantly correlated with hemodynamically
significant renal artery lesions. However, these data
are less helpful or misleading in patients with signifi-
cant bilateral disease, which is common in patients
with fulminant clinical conditions as exemplified by
the patients reported herein. These investigators also
note severe dephasing (signal drop-out) on the
phase-contrast magnetic resonance imaging at the
renal artery lesion in 87% of 52 critically stenotic
renal arteries.12 We consider this latter feature an
important, although not universally present, feature
of hemodynamically significant renal artery stenoses.
Additional information available from the MRA
that is important for treatment planning includes
aortic, visceral, and iliac artery anatomy. Lateral pro-
jections displaying the origin of the celiac axis are
helpful if extra-anatomic bypass grafting is consid-
ered. Three patients in our series underwent hepa-
torenal bypass grafting, and adequacy of celiac axis
inflow was both depicted on the MRA and verified
at operation in these patients. Associated aortic
pathologic evidence in the form of juxtarenal ather-
osclerosis, aneurysm, and/or aortoiliac occlusive
disease are all considerations valuable to the surgeon
in selecting among the various options for renal
revascularization. We previously documented that
MRA was an adequate preoperative imaging modal-
ity before AAA surgery, and an important compo-
nent of treatment planning in patients with AAA
may be the detection of accessory and/or stenotic
renal arteries.13 Also consistent with our previous
experience is the fact that approximately one half of
the patients treated surgically for clinically and
anatomically advanced RVD will require combined
aortic and RAR.14 Finally, the gadolinium nephro-
gram combined with the T1-weighted MRA sagittal
scan provides an accurate determination of renal
length and a qualitative assessment of renal cortical
thickness and function. Ros et al15 and Lawrence et
al16 have emphasized the utility of MRA as a com-
prehensive anatomic and functional renovascular
imaging modality, thereby obviating the need for
preliminary studies such as ultrasound scanning and
renal scintigraphy, and data are available that indi-
cate that renal MRA is a cost-effective screening
study in patients with progressive renal failure. We
use renal MRA in this capacity because, as noted ear-
lier, assessment of renal size and function provide
both indirect evidence of the hemodynamic signifi-
cance of the renal artery lesion and permit some
qualitative assessment of the potential for retrieval of
function with revascularization. In the presence of
total proximal renal artery occlusion, an assessment
of kidney collateral blood flow and thereby infer-
ences as to the patency of the main renal artery
beyond the ostial occlusion can be made from the
gadolinium nephrogram. However, related to direc-
tion and turbulence of flow, the demonstration of
reconstitution of the main renal artery beyond an
ostial occlusion, an important angiographic finding
in totally occluded renal arteries, is not possible with
MRA. In addition to the well-known general limita-
tions of MRA (patient cooperation, claustrophobia,
metallic implants), specific shortcomings in the eval-
uation of renovascular anatomy with MRA include
decreased accuracy in the detection and potential
stenosis of accessory renal arteries and the fact that
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an accurate depiction of renovascular anatomy is
limited to the proximal half of the main renal artery.
Although this may not be an important limitation in
the assessment of atherosclerotic RVD, which typi-
cally involves the ostium and/or proximal renal
artery, it does explain why contrast angiography is
mandatory for the evaluation of fibromuscular or
branch vessel disease.
The ultimate test of any clinical strategy is the
results achieved. The combination of clinical profiling
and MRA produced accurate diagnosis and permitted
specific and appropriate treatment planning (as veri-
fied by operative findings) in 24 of 25 patients. The
one false-positive renal MRA occurred in a patient
with slowly progressive renal dysfunction in an out-
patient setting. Because this patient also had symp-
toms of mesenteric ischemia and a total visceral aortic
segment endarterectomy had been planned, the ren-
ovascular lesion was not pursued further. Treatment
failures in the realm of RVD can result from impreci-
sion in diagnosis, technical failure of reconstruction,
or, more commonly, from the inability to precisely
predict the functional results of revascularization. The
latter issue remains an important consideration, par-
ticularly when the goal of revascularization is preser-
vation of renal function. We previously demonstrated
that up to 25% of patients undergoing RAR for renal
function preservation will ultimately have continued
deterioration in renal function; and among variables
predictive of such an outcome, extreme baseline renal
dysfunction (creatinine level, ‡ 3.0 mg/dL) figures
prominently.17 In this context the present patient
cohort could be considered at high risk for clinical
failure because 14 of 25 patients had such severe
baseline renal dysfunction. Among four early treat-
ment failures, two were related to diagnostic/techni-
cal error and two were due to judgmental errors
(repair of high-grade stenoses without discernible
clinical benefits). However, the gratifying late func-
tional results indicate that appropriate diagnostic and
treatment precision in these high-risk patients, with-
out the morbidity of contrast arteriography, was
accomplished.
We do not advocate replacement of angiography
with MRA for most patients being evaluated for
RVD. The strategy detailed herein is best applied
when the clinical presentation predicts the patholog-
ic condition, which is then confirmed with MRA.
Precision in diagnosis and determination of the need
for, and mode of, renal revascularization should be
guided by contrast arteriography in all but that small
subset of patients for whom the risks of angiography
are considerable, principally those patients with sig-
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nificant azotemia and fulminant clinical conditions.
Even then, certain provisions must be satisfied
before the strategy described herein can be success-
fully applied. First, a close working relationship and
interplay between the vascular surgeon and radiolo-
gist is mandatory to develop expertise in the techni-
cal nuances of obtaining an adequate renal MRA and
the clinical/anatomic correlates thereof. Second,
quality control with the results of renal MRA should
be verified at each institution by an initial compara-
tive experience with contrast angiography. Finally,
significant surgical expertise with the variety of sur-
gical renovascular reconstructive options will be nec-
essary to successfully apply this strategy.
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DISCUSSION
Dr John Mannick (Boston, Mass). I think that using
MRA to make clinical decisions can have problems. But it
seems to me, that from a practical point of view, what you
were showing us is that, as is true in the carotid, MRA is
not very good for subtleties of how stenotic an artery is.
But that once you get a flow gap by MRA that means you
have got a high-grade stenosis, whatever the exact per-
centage might be. Is the flow gap the clue here? If we’re
going to use this on somebody on whom we do not want
to do an angiography, would you be satisfied that a flow
gap will tell you that this is a high-grade stenosis?
Dr Cambria. There now are data available on what spe-
cific radiologic characteristics of MRA are associated with
proving hemodynamically significant stenosis. Signal void
or severe dephasing on the phase contrast study is the sin-
gle best radiographic variable. I do want to emphasize,
however, that the other components of the studies, specif-
ically the intensity of the gadolinium nephrogram, kidney
size, and so forth are also helpful, but obviously not so
helpful in patients with significant bilateral disease. But the
short answer to your question is, if you see a total signal
void, you are on pretty firm ground.
Dr K. Craig Kent (New York, NY). As you know we
have been interested in renal MRA for a number of years
and over the last couple of years have been performing
renal artery bypass grafting quite commonly with MRA.
With such extraordinary results in 15% of your renal artery
bypass grafts, with MRA as the only preoperative test, why
not expand that number? Why do you still recommend
angiography as the gold standard? Do you do any intraop-
erative correlation? Did you measure the stenosis interop-
eratively and then go back and correlate that with your pre-
operative MRA in any of these patients? Excellent work.
Dr Cambria. To answer your second question first. I
started this with intraoperative pressure measurements, a
needle in the aorta and a needle in the distal renal artery. I
abandoned that because I do not much like the blood stain-
ing in the wall of an artery that you might want to be
endarterectomizing and went to simple pulse palpation. All
of these patients had an absent, not present, pulse in the
renal artery beyond the lesion, and I have taken that as rea-
sonable enough evidence of the hemodynamic significance
of the lesion. As you know, from the laws of critical arterial
stenosis, that means a minimum of 75% diameter reduction.
Dr Jens Jorgensen (Portland, Me). Those were very
nice pictures. Unfortunately, we do not routinely get
such nice pictures with MRA. We have begun using
catheter-introduced gadolinium, which we find gives us
a pretty good picture, although not quite as good as the
conventional arteriogram. I would appreciate it if you
would comment on this technique. My second question
relates to the difficulty of correlating the physiologic
versus the anatomic significance of a stenosis. Did you
use any confirmatory studies such as nuclear medicine
scans or duplex ultrasonography?
Dr Cambria. Yes, we do use catheter-based gadolinium
arteriography in certain clinical circumstances in the lower
extremity and in certain circumstances of RVD. I would
point out that that does not obviate the potential risk of
catheter manipulation in the juxtarenal aorta, which is of
course frequently afflicted with significant atherosclerosis.
Your second question about predicting the functional
result of revascularization is the real problem in RVD. We
have not used either duplex or renal scintigraphy to help
with this judgment, because we think it remains largely a
clinical judgment based on, in these patients, their gadolin-
ium nephrograms and the clinical presentation.
Dr Richard Gusberg (New Haven, Conn). I have one
simple question, on the lateral MRA in patients in whom
you might have wanted to do an extra anatomic bypass
graft, how convinced were you that the celiac was okay in
the patients. In the patients who might have some moder-
ate disease, we cannot really tell.
Dr Cambria. An excellent question, obviously from a
surgeon with considerable experience in treating these
patients.
As you know, the celiac will often have a defect in it
that is referable to median arcuate ligament compression.
All of the three patients who underwent hepatorenal
bypass grafting in this cohort had apparently good-look-
ing celiacs on the lateral projection, which was then veri-
fied in the operating room by pressure measurements in
the common hepatic artery. I think if the surgeon thinks
there is any question about the adequacy of celiac inflow,
you best (1) verify in the operating room and (2) be pre-
pared for option B, which in my own hands would be a
right subcostal incision with a graft that originates either
from the aorta or the right iliac artery.
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Your first question, about expanding this policy. Perhaps we
have interpreted our results a bit too conservatively. Recall
that there was one treatment failure in this series, one of 25,
where a patient underwent an operation for a lesion that
was apparently a high-grade stenosis, proved not to be
hemodynamically significant in the operating room, and
obviously underwent an operation that she did not need.
The subtleties of this, as Dr. Mannick pointed out, are most
present in those patients with some degree of stenosis,
where the question is figuring out whether it is a 50% or a
hemodynamically significant stenosis. So, I think caution
needs to be advised. It is impossible to emphasize enough
the importance of having an intimately interested vascular
radiologist to develop this with you. You cannot pull this off
by getting films from a radiologist in abstentia and expect to
have adequate accuracy of diagnosis. At the Massachusetts
General Hospital we have had the great luxury of working
with a whole line of vascular radiologists who have devel-
oped this, and that is the reason that Dr Kaufman is the sec-
ond author on this article.
Dr Dan Gorin (Manchester, New Hampshire). In our
institution, it seems that the interventionalists have
become the gatekeepers for the treatment of this disease.
And the vast majority of RVD is treated endovascularly
before we see it. I am curious whether you think this tech-
nology has been able to at least, in your mind, anatomi-
cally sort out patients who could be treated endovascular-
ly as opposed to surgically?
Dr Cambria. Well, we were also accused of adopting
this policy to keep the cases away from the interventional
radiologists, but one of the short comings of this
approach, obviously, is that it does not address the poten-
tial facility of balloon angioplasty and stent application. I
wonder if a few years from now this report may be of his-
toric interest only.
Dr Frank Logerfo (Boston, Mass). First, do you have
at your institution, the correlation between percent steno-
sis on angiography and the lesions seen on the MRA?
Second, in a practical sense, going back to the data from
Begg and Jergens published in the 1960s, about 65% of
people with aortic aneurysms have hypertension, of which
50% have a renal artery stenosis of 50% or more. So,
should we perform MRAs on every patient with AAA who
has hypertension? So many of them have a 50% or more
renal artery lesion. Third, what about the sustained favor-
able results? Do you have the actual data on the sustained
creatinine decrease after this surgery?
Dr Cambria. To answer your last question first. As
noted in the presentation, the follow-up examinations
ranged from a little over 4 years to 5 months, and we do
have complete follow-up data on the renal function result.
Nineteen of 25 patients had sustained favorable results
between 5 months and 4 years of follow up. On the slides,
although I skipped over it, there were two late functional
failures at 3 years after operation, representing ultimately
judgmental errors; you can debate whether or not 3 years
of improvement in renal function is worth it. We did have
follow-up creatinine levels, both at 1 month, which was on
the scattergram and a late follow up, which is detailed in
the article. With respect to the question about screening
all patients with aortic aneurysm for potential RVD, it is
well recognized in multiple reports that one third of
patients undergoing arteriography for either aneurysm or
occlusive disease will prove to have 50% or greater reno-
vascular stenosis. Fifty percent renal artery stenosis is not
functionally nor hemodynamically significant. Obviously
our study does not address the debate as to how aggres-
sive one should be for screening for RVD; I can tell you
how I do it in my own practice. If there is significant, and
that I understand is a relevant term, hypertension or any
degree of renal insufficiency, I do something to evaluate
for RVD, either an MRA or a contrast arteriography.
With respect to your first question about the correla-
tive information about percent stenosis on angiography
and MRA, that is obviously not available for these patients
who underwent only an MRA. However, the reference I
showed in the background material, was a report that I par-
ticipated in with 30 patients who underwent arteriography
and MRA, with a sensitivity of 100%, using the angiogram
as the gold standard. The specificity was 70%, the specifici-
ty figure being knocked down by those patients with false-
positive MRAs (which is to say, over estimation of the
degree of stenosis). And similar to carotid MRA, you are
not talking about the patients with either wide open arter-
ies or 99% stenosis; you are talking about the subtleties of
the patients with 50% to 75% stenosis.
Unidentified speaker. You presented the 25 patients
who had only MRA. Did you perform MRAs in other
patients, hoping that it might be the only modality, and
then have to use a contrast arteriogram because you could
not get the information? What was the rough percentage
of patients that this was really successful in?
Dr Cambria. I do not have that data; however, I do
not mean to imply that every patient in whom the inten-
tion to treat with MRA alone was adequately examined
with this study. It is not uncommon, even with a contrast
arteriogram, to still have uncertainty about the veracity of
the diagnosis. There are limitations to MRA—patient
cooperation, implants, claustrophobia, and all of those
other things; and there are clearly patients, particularly
those who apparently have multiple renal arteries, with
whom we simply go to arteriography, because MRA alone
is clearly less accurate in detecting and assessing stenosis in
accessory multiple artery situations.
